Authors:
CHANDRAN S
SVENDSEN C
COMPSTON A
SCOLDING N
Citation: S. Chandran et al., REGIONAL POTENTIAL FOR OLIGODENDROCYTE GENERATION IN THE RODENT EMBRYONIC SPINAL-CORD FOLLOWING EXPOSURE TO EGF AND FGF-2, Glia (New York, N.Y. : Print), 24(4), 1998, pp. 382-389
Authors:
CHANDRAN S
SVENDSEN C
COMPSTON A
SCOLDING N
Citation: S. Chandran et al., DIFFERENTIAL OLIGODENDROGENIC POTENTIAL IN THE RODENT EMBRYONIC SPINAL-CORD FOLLOWING EXPOSURE TO EPIDERMAL GROWTH-FACTOR AND FIBROBLAST GROWTH FACTOR-2, Annals of neurology, 44(3), 1998, pp. 153-153
Authors:
BALAN KK
COLES AJ
WRAIGHT EP
CHATTERJEE VK
COMPSTON A
Citation: Kk. Balan et al., THYROID-DYSFUNCTION FOLLOWING ANTILYMPHOCYTE MONOCLONAL-ANTIBODY TREATMENT OF MULTIPLE-SCLEROSIS - SCINTIGRAPHIC ASSESSMENT, The Journal of nuclear medicine, 39(5), 1998, pp. 1156-1156
Authors:
CHATAWAY J
FEAKES R
CORADDU F
GRAY J
DEANS J
FRASER M
ROBERTSON N
BROADLEY S
JONES H
CLAYTON D
GOODFELLOW P
SAWCER S
COMPSTON A
Citation: J. Chataway et al., THE GENETICS OF MULTIPLE-SCLEROSIS - PRINCIPLES, BACKGROUND AND UPDATED RESULTS OF THE UNITED-KINGDOM SYSTEMATIC GENOME SCREEN, Brain (Print), 121, 1998, pp. 1869-1887
Citation: A. Compston, REMYELINATION IN MULTIPLE-SCLEROSIS - A CHALLENGE FOR THERAPY THE 1996 EUROPEAN-CHARCOT-FOUNDATION LECTURE, Multiple sclerosis, 3(2), 1997, pp. 51-70
Authors:
SAWCER S
JONES HB
JUDGE D
VISSER F
COMPSTON A
GOODFELLOW PN
CLAYTON D
Citation: S. Sawcer et al., EMPIRICAL GENOMEWIDE SIGNIFICANCE LEVELS ESTABLISHED BY WHOLE GENOME SIMULATIONS, Genetic epidemiology, 14(3), 1997, pp. 223-229
Authors:
SAWCER S
JONES HB
FEAKES R
GRAY J
SMALDON N
CHATAWAY J
ROBERTSON N
CLAYTON D
GOODFELLOW PN
COMPSTON A
Citation: S. Sawcer et al., A GENOME SCREEN IN MULTIPLE-SCLEROSIS REVEALS SUSCEPTIBILITY LOCI ON CHROMOSOME 6P21 AND 17Q22, Nature genetics, 13(4), 1996, pp. 464-468
Authors:
WING MG
MOREAU T
GREENWOOD J
SMITH RM
HALE G
ISAACS J
WALDMANN H
LACHMANN PJ
COMPSTON A
Citation: Mg. Wing et al., MECHANISM OF FIRST-DOSE CYTOKINE-RELEASE SYNDROME BY CAMPATH 1-H - INVOLVEMENT OF CD16 (FC-GAMMA-RIII) AND CD11A CD18 (LFA-1) ON NK CELLS/, The Journal of clinical investigation, 98(12), 1996, pp. 2819-2826
Authors:
MOREAU T
COLES A
WING M
ISAACS J
HALE G
WALDMANN H
COMPSTON A
Citation: T. Moreau et al., TRANSIENT INCREASE IN SYMPTOMS ASSOCIATED WITH CYTOKINE RELEASE IN PATIENTS WITH MULTIPLE-SCLEROSIS, Brain, 119, 1996, pp. 225-237
Citation: J. Zajicek et al., HUMAN OLIGODENDROCYTES ARE NOT SENSITIVE TO COMPLEMENT - A STUDY OF CD59 EXPRESSION IN THE HUMAN CENTRAL-NERVOUS-SYSTEM, Laboratory investigation, 73(1), 1995, pp. 128-138
Authors:
LUXTON RW
ZEMAN A
HOLZEL H
HARVEY P
WILSON J
KOCEN R
MORGANHUGHES J
MILLER DH
COMPSTON A
THOMPSON EJ
Citation: Rw. Luxton et al., AFFINITY OF ANTIGEN-SPECIFIC IGG DISTINGUISHES MULTIPLE-SCLEROSIS FROM ENCEPHALITIS, Journal of the neurological sciences, 132(1), 1995, pp. 11-19
Citation: N. Robertson et A. Compston, SURVEYING MULTIPLE-SCLEROSIS IN THE UNITED-KINGDOM, Journal of Neurology, Neurosurgery and Psychiatry, 58(1), 1995, pp. 2-6
Authors:
WEBB A
CLARK P
SKEPPER J
COMPSTON A
WOOD A
Citation: A. Webb et al., GUIDANCE OF OLIGODENDROCYTES AND THEIR PROGENITORS BY SUBSTRATUM TOPOGRAPHY, Journal of Cell Science, 108, 1995, pp. 2747-2760
Citation: A. Compston, INTERFERON-BETA AND MULTIPLE-SCLEROSIS - NOT A FINAL-SOLUTION TO THE PROBLEM, British Journal of Hospital Medicine, 53(11), 1995, pp. 547
Citation: A. Compston, THE EPIDEMIOLOGY OF MULTIPLE-SCLEROSIS - PRINCIPLES, ACHIEVEMENTS, AND RECOMMENDATIONS, Annals of neurology, 36, 1994, pp. 190000211-190000217